Ardelyx is a clinical-stage biopharmaceutical company that focuses on developing therapies for gastrointestinal and cardio-renal conditions. The organization employs roughly 340 people and has recorded steady net growth, adding significantly more team members than it has lost through attrition. This hiring momentum reflects ongoing advancement of its drug pipeline and commercial readiness activities.
Sales and Support is Ardelyx’s largest function, accounting for just under half of the workforce with about 170 employees. Business Management and Engineering follow, employing 30 and 26 people respectively, while Healthcare specialists total 24. Core enabling groups—Marketing & Product (22), Finance & Administration (19), Operations (13), Human Resources (11), and Legal (9)—provide additional depth. An "Other" category of 18 employees rounds out the roster, underscoring a balanced mix of commercial, scientific, and corporate roles.
Ardelyx maintains a distributed footprint. Headcounts in Boston and San Francisco are nearly even at a little over 30 employees each, while New York, Philadelphia, Los Angeles, Chicago, Dallas, Denver, and Atlanta host smaller satellite teams. A majority of the workforce—more than two-thirds—is classified under "Other," indicating a sizable remote or field-based population that supports nationwide clinical and commercial operations.